Delivery Order SPE2DB20D3103-SPE2DB24FM6W0
- Not listed
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $4,443.41 firm-fixed price contract is for the delivery of 4,568,475,034 vials of the antibiotic cefazolin. The contract has an ultimate completion date of June 9, 2025 and is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,562,688 vials of Cefazolin 1 GM. The contract is a Delivery Order with a Firm Fixed Price of $5,827.84 and an Ultimate Completion Date of November 3, 2023. The contract is awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a division of the Department of Defense. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award, with ID SPE2DX15D1053|SPE2DX25F6DBL, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract is a $2,167.92 Firm Fixed Price Delivery Order for the supply of 4,566,383,974 units of Cefazolin 2 G/50 ML-Dextroses, a pharmaceutical product. The contract has an ultimate completion date of November 12, 2024 and was awarded on November 8, 2024. Amerisourcebergen Drug Corp is a major...
- This is a $2,377.80 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,683,425 vials of the antibiotic Cefazolin 1 GM. The award has no set-aside designation, indicating open competition. The contract has an ultimate completion date of July 2, 2025. AmerisourceBergen Drug Corp also holds a $999,999,999.00 Indefinite...
- This is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of 4,561,504,751 units of Cefazolin 2 g/50 mL-Dextrose. The $4,749.84 firm fixed-price contract has a completion date of July 17, 2023. Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical...
- This federal contract award from the Defense Logistics Agency (DLA) was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,393.30 firm fixed-price delivery order is for the supply of CEFAZOLIN 2 GM VIALS, a type of antibiotic medication. The contract has a period of performance through June 12, 2025 and is not designated as a set-aside award, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4,563,968,915 units of the pharmaceutical product Cefazolin 2 G/50 ML-Dextroses. The contract, valued at $3,478.11, has an ultimate completion date of March 15, 2024. Amerisourcebergen Drug Corp is the prime contractor on this order, which is part of a larger indefinite delivery contract (IDC) with DLA valued at up...
- This federal contract award, valued at $1,162.19, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Cefazolin 1 gm vials, a type of antibiotic medication. The contract has an ultimate completion date of December 18, 2023 and is a Firm Fixed Price Delivery Order. The contract was not set aside for any specific business type. Amerisourcebergen Drug Corp holds a...
- This federal contract award, with ID SPE2DB20D3101|SPE2DB25FQTJ4, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,881.80 firm fixed-price delivery order is for the supply of 4,566,178,222 units of the drug Cefazolin 1 G/50 ML-Dextroses. The contract has an ultimate completion date of October 23, 2024 and was awarded on October 22, 2024. Amerisourcebergen, a for-profit organization...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,211.80 firm fixed-price delivery order, awarded on August 26, 2024, is for the supply of 4,565,586,219 units of cefazolin 1 g/50 ml-dextrose solution. The contract has an ultimate completion date of August 27, 2024 and does not have a set-aside designation. AmerisourceBergen holds a significant $999,999,999...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB24FM6W0Delivery Order
This federal contract award, SPE2DB20D3103|SPE2DB24FM6W0, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,799.32 firm-fixed-price delivery order is for the supply of 4,563,666,052 vials of Cefazolin 10 GM, a generic antibiotic medication. The contract has an ultimate completion date of February 15, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as Amerisourcebergen. Cencora, Inc. holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order is issued under that broader IDC contract vehicle. The contract does not have a set-aside designation, indicating it was competed on a full and open basis.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.8k | 2/14/24 |